Stay updated on CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial

Sign up to get notified when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record now presents the completed CC-122 plus nivolumab study for unresectable hepatocellular carcinoma, including its eligibility criteria, study design, outcomes, locations, and study documents.
    Difference
    55%
    Check dated 2026-11-09T13:14:32.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0; the page continues to display a 403 error response.
    Difference
    0.2%
    Check dated 2026-11-02T12:41:58.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The study record page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-26T12:45:22.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:07:18.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:45:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now presents a 403 Forbidden error, preventing access to the study record for NCT02859324 on ClinicalTrials.gov. This means the study details and related information are not viewable from this page.
    Difference
    18%
    Check dated 2026-09-21T22:08:07.000Z thumbnail image

Stay in the know with updates to CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.